Interleukin-1ß is a positive regulator of TIARP/STAMP2 gene and protein expression in adipocytes in vitro

FEBS Letters

Volumn 583, Issue 7, 2009, Pages 1196-1200

  Kralisch, Susan ^a   Sommer, Grit ^a   Weise, Sebastian ^a   Lipfert, Jana ^a   Lossner, Ulrike ^a   Kamprad, Manja ^b   Schröck, Kathleen ^c   Bluher, Matthias ^a   Stumvoll, Michael ^a   Fasshauer, Mathias ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Institute of Clinical Immunology and Transfusion Medicine   (Germany)

^c Translational Centre for Regenerative Medicine   (Germany)

Author keywords

Adipocyte; Insulin resistance; Interleukin 1 ; Obesity; STAMP2; TIARP

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; JANUS KINASE 2; MEMBRANE PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN TIARP; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; IL6 PROTEIN, HUMAN; JAK2 PROTEIN, HUMAN; JAK2 PROTEIN, MOUSE; OXIDOREDUCTASE; STEAP4 PROTEIN, HUMAN; TIARP PROTEIN, MOUSE;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYME CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; UPREGULATION; ANIMAL; BIOSYNTHESIS; CELL STRAIN 3T3; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; GENE EXPRESSION REGULATION; INSULIN RESISTANCE; MESENCHYMAL STEM CELL; METABOLISM; PHYSIOLOGY;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; GENE EXPRESSION REGULATION; HUMANS; INSULIN RESISTANCE; INTERLEUKIN-1BETA; INTERLEUKIN-6; JANUS KINASE 2; MEMBRANE PROTEINS; MESENCHYMAL STEM CELLS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; NF-KAPPA B; OXIDOREDUCTASES; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 62849089639     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.03.015     Document Type: Article

References (32)

1. Sjoholm A., and Nystrom T. Inflammation and the etiology of type 2 diabetes. Diabetes Metab. Res. Rev. 22 (2006) 4-10
2. Bastard J.P., Maachi M., Van Nhieu J.T., Jardel C., Bruckert E., Grimaldi A., Robert J.J., Capeau J., and Hainque B. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J. Clin. Endocrinol. Metab. 87 (2002) 2084-2089
3. Bruun J.M., Verdich C., Toubro S., Astrup A., and Richelsen B. Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men. Eur. J. Endocrinol. 148 (2003) 535-542
4. Hotamisligil G.S., Arner P., Caro J.F., Atkinson R.L., and Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 95 (1995) 2409-2415
5. Pickup J.C., Mattock M.B., Chusney G.D., and Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40 (1997) 1286-1292
6. Uysal K.T., Wiesbrock S.M., Marino M.W., and Hotamisligil G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389 (1997) 610-614
7. Jager J., Gremeaux T., Cormont M., Marchand-Brustel Y., and Tanti J.F. Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 148 (2007) 241-251
8. Lagathu C., Yvan-Charvet L., Bastard J.P., Maachi M., Quignard-Boulange A., Capeau J., and Caron M. Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes. Diabetologia 49 (2006) 2162-2173
9. Barksby H.E., Lea S.R., Preshaw P.M., and Taylor J.J. The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin. Exp. Immunol. 149 (2007) 217-225
10. He J., Usui I., Ishizuka K., Kanatani Y., Hiratani K., Iwata M., Bukhari A., Haruta T., Sasaoka T., and Kobayashi M. Interleukin-1alpha inhibits insulin signaling with phosphorylating insulin receptor substrate-1 on serine residues in 3T3-L1 adipocytes. Mol. Endocrinol. 20 (2006) 114-124
11. Fasshauer M., Kralisch S., Klier M., Lossner U., Bluher M., Klein J., and Paschke R. Insulin resistance-inducing cytokines differentially regulate SOCS mRNA expression via growth factor- and Jak/Stat signaling pathways in 3T3-L1 adipocytes. J. Endocrinol. 181 (2004) 129-138
12. Thomas H.E., Irawaty W., Darwiche R., Brodnicki T.C., Santamaria P., Allison J., and Kay T.W. IL-1 receptor deficiency slows progression to diabetes in the NOD mouse. Diabetes 53 (2004) 113-121
13. Larsen C.M., Faulenbach M., Vaag A., Volund A., Ehses J.A., Seifert B., Mandrup-Poulsen T., and Donath M.Y. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. New Engl. J. Med. 356 (2007) 1517-1526
14. Sommer G., Weise S., Kralisch S., Scherer P.E., Lossner U., Bluher M., Stumvoll M., and Fasshauer M. The adipokine SAA3 is induced by interleukin-1ß in mouse adipocytes. J. Cell Biochem. 104 (2008) 2241-2247
15. Sommer G., Weise S., Kralisch S., Lossner U., Bluher M., Stumvoll M., and Fasshauer M. Lipocalin-2 is induced by interleukin-1beta in murine adipocytes in vitro. J. Cell Biochem. 106 (2008) 103-108
16. Weise S., Kralisch S., Sommer G., Lossner U., Bluher M., Stumvoll M., and Fasshauer M. TIMP-1 mRNA production and protein secretion are induced by IL-1ß in 3T3-L1 adipocytes. J. Endocrinol. 198 (2008) 169-174
17. Moldes M., Lasnier F., Gauthereau X., Klein C., Pairault J., Feve B., and Chambaut-Guerin A.M. Tumor necrosis factor-alpha-induced adipose-related protein (TIARP), a cell-surface protein that is highly induced by tumor necrosis factor-alpha and adipose conversion. J. Biol. Chem. 276 (2001) 33938-33946
18. Korkmaz C.G., Korkmaz K.S., Kurys P., Elbi C., Wang L., Klokk T.I., Hammarstrom C., Troen G., Svindland A., Hager G.L., and Saatcioglu F. Molecular cloning and characterization of STAMP2, an androgen-regulated six transmembrane protein that is overexpressed in prostate cancer. Oncogene 24 (2005) 4934-4945
19. Wellen K.E., Fucho R., Gregor M.F., Furuhashi M., Morgan C., Lindstad T., Vaillancourt E., Gorgun C.Z., Saatcioglu F., and Hotamisligil G.S. Coordinated regulation of nutrient and inflammatory responses by STAMP2 is essential for metabolic homeostasis. Cell 129 (2007) 537-548
20. Fasshauer M., Klein J., Kralisch S., Lossner U., Klier M., Bluher M., and Paschke R. Growth hormone is a positive regulator of tumor necrosis factor a-induced adipose related protein in 3T3-L1 adipocytes. J. Endocrinol. 178 (2003) 523-531
21. Fasshauer M., Kralisch S., Klier M., Lossner U., Bluher M., Chambaut-Guerin A.M., Klein J., and Paschke R. Interleukin-6 is a positive regulator of tumor necrosis factor alpha-induced adipose-related protein in 3T3-L1 adipocytes. FEBS Lett. 560 (2004) 153-157
22. Kralisch S., Klein J., Lossner U., Bluher M., Paschke R., Stumvoll M., and Fasshauer M. Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes. Am. J. Physiol. Endocrinol. Metab. 289 (2005) E586-E590
23. Laborda J. 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucl. Acids Res. 19 (1991) 3998
24. Catalan V., Gomez-Ambrosi J., Rotellar F., Silva C., Rodriguez A., Salvador J., Gil M.J., Cienfuegos J.A., and Fruhbeck G. Validation of endogenous control genes in human adipose tissue: relevance to obesity and obesity-associated type 2 diabetes mellitus. Horm. Metab. Res. 39 (2007) 495-500
25. Klein J., Fasshauer M., Ito M., Lowell B.B., Benito M., and Kahn C.R. Beta(3)-adrenergic stimulation differentially inhibits insulin signaling and decreases insulin-induced glucose uptake in brown adipocytes. J. Biol. Chem. 274 (1999) 34795-34802
26. Dinarello C.A. Interleukin-1. Cytokine Growth Fact. Rev. 8 (1997) 253-265
27. Sims J.E., Acres R.B., Grubin C.E., McMahan C.J., Wignall J.M., March C.J., and Dower S.K. Cloning the interleukin 1 receptor from human T cells. Proc. Natl. Acad. Sci. USA 86 (1989) 8946-8950
28. Cao Z., Henzel W.J., and Gao X. IRAK: a kinase associated with the interleukin-1 receptor. Science 271 (1996) 1128-1131
29. Barnes P.J., and Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. New Engl. J. Med. 336 (1997) 1066-1071
30. Doi M., Shichiri M., Katsuyama K., Ishimaru S., and Hirata Y. Cytokine-activated Jak-2 is involved in inducible nitric oxide synthase expression independent from NF-kappaB activation in vascular smooth muscle cells. Atherosclerosis 160 (2002) 123-132
31. Stylianou E., and Saklatvala J. Interleukin-1. Int. J. Biochem. Cell Biol. 30 (1998) 1075-1079
32. Reddy S.A., Huang J.H., and Liao W.S. Phosphatidylinositol 3-kinase in interleukin 1 signaling. Physical interaction with the interleukin 1 receptor and requirement in NFkappaB and AP-1 activation. J. Biol. Chem. 272 (1997) 29167-29173